SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001104659-19-065521
Filing Date
2019-11-19
Accepted
2019-11-19 17:26:50
Documents
4

Document Format Files

Seq Description Document Type Size
1 424B5 tm1923400-1_424b5.htm 424B5 305031
2 GRAPHIC tm1923400-1_424b5img003.jpg GRAPHIC 14313
3 GRAPHIC tm1923400-1_424b5img004.jpg GRAPHIC 14340
4 GRAPHIC tv478928_img1.jpg GRAPHIC 14313
  Complete submission text file 0001104659-19-065521.txt   365670
Mailing Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014 212-554-4366
Checkpoint Therapeutics, Inc. (Filer) CIK: 0001651407 (see all company filings)

IRS No.: 472568632 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-221493 | Film No.: 191232409
SIC: 2834 Pharmaceutical Preparations